-
NPS Pharma Prices Public Offering Of 6 Mln Common Stock
5/21/2013
|
|
|
-
NPS Pharmaceuticals Commences Public Offering Of 6 Mln Shares Of Its Common Stock
5/20/2013
|
-
NPS Pharmaceuticals Q1 Loss/Shr $0.09 Vs. Loss $0.12 Last Year
5/9/2013
|
|
|
|
|
|
|
|
|
|
|
-
NPS Pharma And Takeda Says NPS Regains Full Worldwide Rights To Teduglutide, Recombinant Human Parathyroid Hormone 1-84
3/19/2013
|